Published in J Appl Physiol on July 01, 1973
Integrative regulation of human brain blood flow. J Physiol (2014) 1.85
The pathogenesis of carbon monoxide encephalopathy in the acute phase--physiological and morphological correlation. Acta Neuropathol (1981) 1.22
Influence of high altitude on cerebral blood flow and fuel utilization during exercise and recovery. J Physiol (2014) 0.93
The interaction of carbon dioxide and hypoxia in the control of cerebral blood flow. Pflugers Arch (2012) 0.90
Cerebral blood flow in the elderly: impact of hypertension and antihypertensive treatment. Cardiovasc Drugs Ther (1991) 0.89
Brain blood flow in Andean and Himalayan high-altitude populations: evidence of different traits for the same environmental constraint. J Cereb Blood Flow Metab (2010) 0.82
PET in Cerebrovascular Disease. PET Clin (2010) 0.80
Hypoxemia, oxygen content, and the regulation of cerebral blood flow. Am J Physiol Regul Integr Comp Physiol (2015) 0.78
Effect of plasma exchange on blood viscosity and cerebral blood flow. Br Med J (Clin Res Ed) (1982) 0.76
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97
Understanding the biologic basis of migraine. N Engl J Med (1994) 5.25
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet (1999) 4.81
Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol (1991) 4.78
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ (1991) 4.46
Autoregulation of brain circulation in severe arterial hypertension. Br Med J (1973) 4.11
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet (1983) 3.01
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. Diabetes Care (2000) 2.97
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86
A yeast and a human CCAAT-binding protein have heterologous subunits that are functionally interchangeable. Cell (1988) 2.84
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) (1982) 2.75
CGRP may play a causative role in migraine. Cephalalgia (2002) 2.40
Questionnaire versus clinical interview in the diagnosis of headache. Headache (1991) 2.36
Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) (1987) 2.35
Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia (1992) 2.33
Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration. Arch Neurol (1988) 2.30
Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia (1996) 2.29
Regional cerebral blood flow in man determined by the initial slope of the clearance of intra-arterially injected 133Xe. Stroke (1974) 2.26
Mechanisms of edema formation in myxedema--increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med (1979) 2.21
Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health (1992) 2.12
Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet (1991) 2.11
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology (2000) 2.10
Determination of relative CMRO2 from CBF and BOLD changes: significant increase of oxygen consumption rate during visual stimulation. Magn Reson Med (1999) 2.06
Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol (1981) 2.03
Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia (2006) 2.01
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ (1996) 2.00
Phosphorylation regulates in vivo interaction and molecular targeting of serine/arginine-rich pre-mRNA splicing factors. J Cell Biol (1999) 2.00
Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med (1990) 1.99
Symptomatic and nonsymptomatic headaches in a general population. Neurology (1992) 1.99
The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain (2006) 1.97
Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol (1995) 1.96
Increased familial risk and evidence of genetic factor in migraine. BMJ (1995) 1.96
A nosographic analysis of the migraine aura in a general population. Brain (1996) 1.91
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int (2000) 1.85
Cerebral blood flow velocities are reduced during attacks of unilateral migraine without aura. Cephalalgia (1995) 1.82
Persistent resetting of the cerebral oxygen/glucose uptake ratio by brain activation: evidence obtained with the Kety-Schmidt technique. J Cereb Blood Flow Metab (1995) 1.82
Premonitory symptoms in migraine: an electronic diary study. Neurology (2003) 1.81
Does the release of potassium from astrocyte endfeet regulate cerebral blood flow? Science (1987) 1.81
Is diabetic nephropathy an inherited complication? Kidney Int (1992) 1.79
Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels. Ann Neurol (1981) 1.75
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J (Clin Res Ed) (1986) 1.68
Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia (1994) 1.68
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. J Neurol Sci (2011) 1.66
Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology (2010) 1.66
Pressure-controlled palpation: a new technique which increases the reliability of manual palpation. Cephalalgia (1995) 1.64
Regional differences in the CBF and BOLD responses to hypercapnia: a combined PET and fMRI study. Neuroimage (2000) 1.64
Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia (1996) 1.62
Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS. Neurology (1998) 1.62
Generalizable patterns in neuroimaging: how many principal components? Neuroimage (1999) 1.61
Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease. Scand J Med Sci Sports (2001) 1.60
Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group. Neurology (1994) 1.59
Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum (1997) 1.58
Presentation of a new instrument: the diagnostic headache diary. Cephalalgia (1992) 1.57
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int (2001) 1.55
Muscle palpation with controlled finger pressure: new equipment for the study of tender myofascial tissues. Pain (1994) 1.54
A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia (1981) 1.53
Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia (1981) 1.53
Interrelations between migraine and tension-type headache in the general population. Arch Neurol (1992) 1.53
Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke (1994) 1.52
Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet (1999) 1.52
Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes (1995) 1.51
Regulation of cerebral blood flow as a single function of the interstitial pH in the brain. A hypothesis. Acta Neurol Scand (1966) 1.49
Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur J Neurol (2003) 1.49
Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia (1990) 1.49
Regional blood flow in internal carotid distribution during migraine attack. Br Med J (1969) 1.47
Monitoring kidney function in diabetic nephropathy. Diabetologia (1994) 1.47
Diagnosis and management of migraine. BMJ (1996) 1.47
Botulinum toxin in headache treatment: the end of the road? Cephalalgia (2006) 1.46
The effect of intracarotid epinephrine, norepinephrine, and angiotensin on the regional cerebral blood flow in man. Neurology (1972) 1.46
Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int (2000) 1.46
Regional cerebral blood flow in acute apoplexy. The "luxury perfusion syndrome" of brain tissue. Arch Neurol (1967) 1.46
Progression of diabetic nephropathy. Kidney Int (2001) 1.46
Diabetic nephropathy and arterial hypertension. Diabetologia (1983) 1.45
Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers. Cephalalgia (2010) 1.45
Nitroglycerin-induced headache is not dependent on histamine release: support for a direct nociceptive action of nitric oxide. Cephalalgia (1994) 1.44
Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain (1999) 1.43
Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1986) 1.41
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia (1994) 1.40
Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res (1984) 1.40
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care (1998) 1.40
The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia (2005) 1.39
The International classification of headache disorders, 2nd edn (ICDH-II). J Neurol Neurosurg Psychiatry (2004) 1.39
Evaluation of pericranial myofascial nociception by pressure algometry. Reproducibility and factors of variation. Cephalalgia (1992) 1.39
Exteroceptive suppression of temporal muscle activity is normal in chronic tension-type headache and not related to actual headache state. Cephalalgia (1996) 1.39
Myofibre damage in human skeletal muscle: effects of electrical stimulation versus voluntary contraction. J Physiol (2007) 1.38
[Decreased pain threshold and tolerance in patients with chronic tension headache]. Ugeskr Laeger (1997) 1.38
[Sumatriptan (Imigran) to patients with hemiplegic migraine?]. Ugeskr Laeger (1992) 1.38
[Are psychiatric diseases brain diseases?]. Ugeskr Laeger (1999) 1.38
Pressure-sensitive devices. Pain (1995) 1.38
Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol (1983) 1.36
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst (2000) 1.35
Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus. Diabet Med (2001) 1.34